NITEL BETA-25
Description
- Combines Telmisartan (ARB) and Metoprolol (beta-blocker)
- Dual-action formula for superior blood pressure control
- Reduces heart rate and cardiac workload
- Lowers risk of heart attacks, strokes, and heart failure
- Provides 24-hour efficacy with once-daily extended-release dosing
- Ideal for patients with hypertension and cardiovascular conditions
- Improves vascular and heart health simultaneously
Composition
TELMISARTAN-40 MG, METOPROLOL-25 MG
Benefits
NITEL BETA-25 provides enhanced antihypertensive efficacy by targeting both the vascular and cardiac components of high blood pressure. Telmisartan ensures long-lasting vasodilation, while Metoprolol controls heart rate and reduces cardiac output. This combination not only lowers blood pressure effectively but also helps in managing heart rhythm disturbances, angina, and in some cases, heart failure. With once-daily dosing, NITEL BETA-25 improves patient adherence and offers sustained 24-hour control, making it ideal for long-term blood pressure and cardiovascular risk management.
Introduction
NITEL BETA-25 is a dual-action antihypertensive medication combining Telmisartan 40 mg, an angiotensin II receptor blocker (ARB), and Metoprolol Succinate 25 mg, a beta-blocker in an extended-release formulation. This combination is designed to provide comprehensive control of high blood pressure and reduce the risk of cardiovascular events such as heart attacks and strokes. Telmisartan works by relaxing blood vessels, while Metoprolol slows the heart rate and reduces the heart's workload. Together, they offer synergistic blood pressure reduction and improved heart health, making NITEL BETA-25 an effective therapy for patients with hypertension and co-existing cardiovascular risks.
